Viewing nowRemicote Extended-Release Capsule 2 mg (Emedastine Fumarate Extended-Release Granule)
Emedastine Fumarate Extended-Release Granules 155mg
Prescription medication
Kolon Pharmaceutical Co., Ltd.

MFDS item code 199400514 · Approved 1994.03.31 · Insurance code 670300290
Relief of skin conditions (e.g., hives, eczema, and itchy skin) and allergic rhinitis
This medication is used for allergic rhinitis, urticaria, eczema, dermatitis, skin itching, and pruritic rash symptoms related to skin and allergies.
Adults: Administer 1~2 mg of emedastine fumarate per dose orally 2 times daily, after breakfast and at bedtime. The dose may be adjusted according to symptoms.
This medication should be used with caution in patients with liver dysfunction or a history of liver disorders, as it may cause liver function abnormalities. This medication contains the dye Yellow No. 5; patients who have had allergies or hypersensitivity reactions to this component should take it with caution. As this medication may cause drowsiness, it is advisable to avoid driving vehicles or operating dangerous machinery. Higher doses may exacerbate drowsiness, so dose adjustments should be made carefully. Patients receiving long-term steroid therapy should gradually decrease the steroid while taking this medication and must be monitored by healthcare professionals. For seasonal symptoms, it is best to start taking this medication before symptoms begin and continue until symptoms subside. This medication has a central nervous system depressant effect, so combining it with sedatives or antihistamines may potentiate its effects, requiring caution. Alcohol consumption may worsen side effects like drowsiness; therefore, it is advisable to avoid alcohol. Pregnant women or those who may become pregnant should only take this medication based on a healthcare professional's advice, as its safety is not well established. Breastfeeding women should avoid taking this medication, as it may be excreted in breast milk. If necessary, it is preferable to discontinue breastfeeding temporarily. Caution is advised as safety for infants and young children has not been sufficiently established. Elderly patients may have diminished physical function, so it's best to start with a lower dose and take it cautiously. This medication may affect allergy test results if taken before testing; therefore, do not take it before such tests. Being an extended-release capsule, it must be swallowed whole and must not be opened, chewed, or crushed for consumption. Store in a safe place out of reach of children, and avoid transferring the medication to another container, as this may lead to accidents or quality degradation.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture intrusion, kept away from direct sunlight, and stored at room temperature. Following appropriate storage methods helps maintain the medication's effectiveness for a longer period.
An orange hard capsule filled with white granules.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEmedastine Fumarate Extended-Release Granules 155mg
Prescription medication
Kolon Pharmaceutical Co., Ltd.

Emedastine Fumarate Extended-Release Granules 155mg
Prescription medication
Kolon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.